Multispectral Ophthalmology Tech Firm Annidis Replaces President

Annidis Corp. has terminated its employment agreement with President Nick Ribaric by mutual agreement. Ribaric remains on the company's board of directors.

Michael Crowley, CEO, assumed the role of interim president Jan. 1.

Annidis has developed an imaging platform technology based on multispectral imaging for noninvasive eye disease identification and management.

For more information, visit www.annidis.com.





LATEST NEWS

• Optimax Names Joseph Spilman CEO
  Nov 25, 2024
• Shape of a Single Photon Revealed with New Theory
  Nov 25, 2024
• Optogenetics Technique Could Replace Surgical Treatments for Seizures
  Nov 25, 2024
• HOLOEYE Partners with Fraunhofer IPMS on Microdisplay
  Nov 22, 2024
• PI Expands German Production Site: Week in Brief: 11/22/24
  Nov 22, 2024
• Lightsynq Emerges from Stealth with $18M Series A
  Nov 21, 2024
• REMBRANDT Project Collaborators to Advance Microwave Photonics
  Nov 21, 2024
• Quasicrystals Create Light Vortices to Transmit More Data with Fiber Optics
  Nov 21, 2024